Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CFDA approves Gilead’s Sovaldi for chronic hepatitis C treatment

pharmaceufical-technologySeptember 27, 2017

Tag: CFDA , Gilead’s Sovaldi , chronic hepatitis C

PharmaSources Customer Service